 |
 |
hi all below is a summary listing of medical article citations which contain references to Parkinson's disease [PD] and which have been added to the PubMed WWWeb site in the past 30 days at: <http://www.ncbi.nlm.nih.gov/PubMed/> entering the PMID number in the search window there will take you to an abstract [synopsis] of the article [if one is available on-line] in any case, the full articles are accessible directly from the relevant medical journal maybe on the web [at a cost] or at a good library [at no cost] or maybe even at your own neurologist's office! Eeucation + Titration R US janet ----------------------------------------------------------------- Flunarizine improves the survival of grafted dopaminergic neurons. PMID: 10613492 Endogenous DA-mediated feedback inhibition of DA neurons: Involvement of both D(1)- and D(2)-like receptors. PMID: 10611636 Central adenosine A(2A) receptors: an overview. PMID: 10611496 Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography. PMID: 10611366 Pergolide monotherapy for PD. PMID: 10610397 Mortality from PD and other causes in men who were prisoners of war in the Far East. PMID: 10609817 Copper, ceruloplasmin, superoxide dismutase and iron parameters in PD. PMID: 10608487 Pesticide study aids PD research. PMID: 10605962 Fetal pig neural cells for PD. PMID: 10605960 Pramipexole in the treatment of PD. PMID: 10605552 Management of neurodegenerative disorders. PMID: 10605544 The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat. PMID: 10602339 GDNF triggers a novel ret-independent src kinase family-coupled signaling via a GPI-linked GDNF receptor alpha1. PMID: 10601639 Unilateral dopamine denervation blocks corticostriatal LTP. PMID: 10601483 Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of PD. PMID: 10600402 Treatment of PD with ropinirole after pergolide-induced retroperitoneal fibrosis. PMID: 10600093 An overnight switch to ropinirole therapy in patients with PD. PMID: 10599874 Respiratory chain enzyme activities in spermatozoa from untreated PD patients. PMID: 10599873 Identification and distribution of Parkin in rat brain. PMID: 10599851 Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. PMID: 10599789 Evaluation of surgery for PD: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. PMID: 10599758 Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced PD: results of a randomized, blinded pilot study. PMID: 10598706 Source memory in PD. PMID: 10597569 Dopamine receptors: physiological understanding to therapeutic intervention potential. PMID: 10596903 Changes in the spike activity of neurons in the ventrolateral nucleus of the thalamus in humans during performance of a voluntary movement. PMID: 10596786 Two novel point mutations of mitochondrial tRNA genes in histologically confirmed PD. PMID: 10369889 A rapid method for the evaluation of compounds with mitochondria-protective properties. PMID: 10595713 The measurement of tremor using a velocity transducer: comparison to simultaneous recordings using transducers of displacement, acceleration and muscle activity. PMID: 10595702 Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat. PMID: 10595430 Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats. PMID: 10594343 Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in PD Are detectable by an advanced silver-staining technique. PMID: 10541868 Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia. PMID: 10541734 The alpha-synuclein gene is not a major risk factor in familial PD. PMID: 10541595 Pathophysiology of secondary depressions in the elderly. PMID: 10593701 Medical treatment of later-stage motor problems of PD. PMID: 10593354 Contribution of Neurophysiological Guidance to Stereotactic Posteroventral Pallidotomy for PD. PMID: 10592120 Manganese exposure in foundry furnacemen and scrap recycling workers. PMID: 10592008 Effects of visual feedback on manual tracking and action tremor in PD. PMID: 10591921 The control of an action in PD. PMID: 10591901 Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeys. PMID: 10591875 Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP. PMID: 10591873 Metabolic transformation of deprenyl enantiomers in rats. PMID: 10591057 Lack of clinical improvement in patients with PD after low and high frequency repetitive transcranial magnetic stimulation. PMID: 10590961 Therapeutic value of exercise training in PD. PMID: 10589855 Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in PD. PMID: 10589547 Functional characterization and expression of thalamic GABA(B) receptors in a rodent model of PD. PMID: 10587084 Regional distribution of parkinsonism-preventing endogenous tetra-hydro-iso-quinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain. PMID: 10586977 Habitual mandibular dislocation in two patients with PD. PMID: 10586632 Phase 2 clinical study of 123I-IBF, a dopamine D2 receptor imaging agent, to evaluate clinical efficacy and safety in PD and Parkinson syndromes. PMID: 10586546 A prospective comparison between three-dimensional magnetic resonance imaging and ventriculography for target-coordinate determination in frame-based functional stereotactic neurosurgery. PMID: 10584834 Treatment of drooling in PD with botulinum toxin. PMID: 10584695 Striatal D2 dopamine receptor status in PD: an [18F]dopa and [11C]raclopride PET study. PMID: 10584682 Worsening of motor features of parkinsonism with olanzapine. PMID: 10584679 Worsening of motor performance in patients with PD following transdermal nicotine administration. PMID: 10584678 Decreased concentration of annexin V in parkinsonian cerebrospinal fluid: speculation on the underlying cause. PMID: 10584677 Visuomotor performance in patients with essential tremor. PMID: 10584674 Changes in handwriting resulting from bilateral high-frequency stimulation of the subthalamic nucleus in Parkinson's disease. PMID: 10584671 Does deep brain stimulation of the nucleus ventralis intermedius affect postural control and locomotion in PD? PMID: 10584670 Unilateral pallidotomy in advanced PD: a retrospective study of 26 patients. PMID: 10584669 Progression of falls in postmortem-confirmed parkinsonian disorders. PMID: 10584668 The effect of dopamine agonist therapy on dopamine transporter imaging in PD. PMID: 10584667 Environmental risk factors in PD. PMID: 10584666 Excessive daytime sleepiness and sleep benefit in PD: a community-based study. PMID: 10584665 Levodopa in the treatment of PD: a consensus meeting. PMID: 10584663 Mitochondrial myopathies and encephalomyopathies. PMID: 10583431 Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury. PMID: 10582622 Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures. PMID: 10582607 Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey. PMID: 10581645 Fall events described by people with PD: implications for clinical interviewing and the research agenda. PMID: 10581625 Environmental, medical, and family history risk factors for PD: A New England-based case control study. PMID: 10581500 Analysis of ERDA1, CTG18.1, and uncloned CAG/CTG repeat sequences in familial PD with anticipation. PMID: 10581499 Bilateral subthalamic nucleus stimulation improves frontal cortex function in PD: An electrophysiological study of the contingent negative variation. PMID: 10581229 Neuropsychological outcome following unilateral pallidotomy. PMID: 10581217 Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of PD. PMID: 10581083 NOS knockouts and neuroprotection. PMID: 10581072 Expression of MHC class I heavy chain and beta2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons. PMID: 10580816 Comparison of the effects of dopaminergic and serotonergic activity in the CNS on the activity of the immune system. PMID: 10580803 A stereological study on the neuroprotective actions of acute modafinil treatment on MPTP-induced nigral lesions of the male black mouse. PMID: 10580713 Auditory brainstem responses in patients with autonomic failure with PD and multiple system atrophy. PMID: 10580301 Protein isoaspartyl methyltransferase protects from bax-induced apoptosis. PMID: 10580153 Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment. PMID: 10579213 Embryonal nerve tissue transplantation in the therapy of PD: current issues. PMID: 10578542 Dopamine D4 receptors: significance for molecular psychiatry at the millennium. PMID: 10578234 Visual hallucinations, white matter lesions and disease severity in PD. PMID: 10577270 Fetal cells help Parkinson's patients. PMID: 10577234 More about parkinsonism after taking ecstasy. PMID: 10577097 More about parkinsonism after taking ecstasy. PMID: 10577096 More about parkinsonism after taking ecstasy. PMID: 10577095 The freezing of time as a presenting symptom of PD. PMID: 10577086 Botulinum toxin is a useful treatment in excessive drooling in saliva. PMID: 10577041 Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. PMID: 10553990 Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early PD: a double-tracer positron emission tomography study. PMID: 10553989 A neuropsychological comparison of demented and nondemented patients with PD. PMID: 10497689 ----------------------------------------------------------------- janet marie paterson 52 now / 41 dx / 37 onset http://www.geocities.com/SoHo/Village/6263/ 613 256 8340 PO Box 171 Almonte Ontario Canada K0A 1A0